在肝细胞癌无创标志物的新领域。 - Suppr

Suppr

超能文献

In the new area of noninvasive markers of hepatocellular carcinoma.

作者信息

Paradis Valérie, Bedossa Pierre

出版信息

J Hepatol. 2007 Jan;46(1):9-11. doi: 10.1016/j.jhep.2006.10.006. Epub 2006 Nov 7.

DOI:10.1016/j.jhep.2006.10.006

PMID:17112623

Abstract

摘要

相似文献

In the new area of noninvasive markers of hepatocellular carcinoma.

J Hepatol. 2007 Jan;46(1):9-11. doi: 10.1016/j.jhep.2006.10.006. Epub 2006 Nov 7.

A concise review of serum markers for hepatocellular cancer.

Cancer Detect Prev. 2007;31(1):35-44. doi: 10.1016/j.cdp.2006.11.003. Epub 2007 Feb 12.

Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma.

J Hepatobiliary Pancreat Surg. 2006;13(3):239-44. doi: 10.1007/s00534-005-1069-x.

Alpha-2 macroglobulin: an additional marker for diagnosis of hepatocellular carcinoma.

J Assoc Physicians India. 1987 Apr;35(4):288-9.

Hepatobiliary Pancreat Dis Int. 2007 Feb;6(1):9-11.

[Molecular markers for early diagnosis of hepatocellular carcinoma].

Zhonghua Gan Zang Bing Za Zhi. 2004 Aug;12(8):492.

The copper/zinc ratio in patients with hepatocellular carcinoma.

J Gastroenterol. 2003;38(1):104-5. doi: 10.1007/s005350300016.

Serum golgi phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.

Hepatology. 2009 Nov;50(5):1682. doi: 10.1002/hep.23244.

[Screening of serum biomarkers in hepatocellular carcinoma by SELDI technique: a preliminary study].

Zhonghua Gan Zang Bing Za Zhi. 2007 Apr;15(4):298-9.

[Amplification of peripheral blood insulin-like growth factor II-mRNA and its clinical significance in the diagnosis of hepatocellular carcinoma].

Zhonghua Gan Zang Bing Za Zhi. 2003 Nov;11(11):695-6.

引用本文的文献

Establishment of a Novel Mouse Hepatocellular Carcinoma Model for Dynamic Monitoring of Tumor Development by Bioluminescence Imaging.

Front Oncol. 2022 Feb 17;12:794101. doi: 10.3389/fonc.2022.794101. eCollection 2022.

A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.

Cancer Sci. 2022 Feb;113(2):411-422. doi: 10.1111/cas.15217. Epub 2021 Dec 14.

Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver Genes.

Cancers (Basel). 2020 May 18;12(5):1271. doi: 10.3390/cancers12051271.

Relationship between platelet-based models and the prognosis of patients with malignant hepatic tumors.

Oncol Lett. 2020 Mar;19(3):2384-2396. doi: 10.3892/ol.2020.11317. Epub 2020 Jan 17.

Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.

Clin Immunol. 2014 May-Jun;152(1-2):127-39. doi: 10.1016/j.clim.2014.03.007. Epub 2014 Mar 22.

Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.

Cancer Lett. 2010 Mar 1;289(1):32-9. doi: 10.1016/j.canlet.2009.07.016. Epub 2009 Aug 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验